{
  "docId": "019de516-01ce-701d-bd9b-acac15fa9fab",
  "docSlug": "a13be9775a99db49a0c5c2ac3ee2ea88",
  "documentTitle": "Oculis | Investor Conference Presentation Deck | 39 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 39,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-01ce-701d-bd9b-acac15fa9fab/5",
  "deckHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab",
  "deckJsonHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab.json",
  "deckAnchorHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.07,
        "w": 0.85,
        "x": 0.04,
        "y": 0.89
      },
      "kind": "source-note",
      "text": "OCS-01 is based on the OPTIREACH® technology, OCS-02 is a single chain antibody fragment (ScFv) against TNFα and OCS-05 is a SGK-2 activator peptidomimetic small molecule with novel MoA targeting the activation of the trophic factor pathways. (1) Geographic Atrophy (GA). (2) Diabetic Retinopathy (DR). (3) Age-related Macular Degeneration (AMD). (4) Retinal Vein Occlusion (RVO).",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "70136375-9be6-4a66-bc20-a281b50f2f03",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.71,
        "w": 0.92,
        "x": 0.04,
        "y": 0.14
      },
      "kind": "table",
      "text": "Product Candidate, Investigational Indication(s), Pre-clinical, Phase 1, Phase 2, Phase 3, 2023, 2024, Catalysts, OCS-01 OPTIREACH® technology, DIABETIC MACULAR EDEMA, INFLAMMATION AND PAIN FOLLOWING OCULAR SURGERY, CYSTOID MACULAR EDEMA, 1º endpt. met Stage 1, Ph 3 readout, NDA, PoC readout, OCS-02 Topical TNFα Inhibitor, DRY EYE DISEASE, UVEITIS, Ph 2b readout, Ph 2b readout, OCS-05 SGK2 Activator, ACUTE OPTIC NEURITIS, GLAUCOMA, GA(1), DR(2), NEUROTROPHIC KERATITIS, PoC readout, OCS-03, CORNEAL NV, PTERYGIUM, OCS-04, CORNEAL TRANSPLANT, (Undisclosed), WET-AMD(3), RVO(4), DR",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1a631d81-a16f-4798-8dc6-b8364c0c4c19",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.83,
        "x": 0.028,
        "y": 0.04
      },
      "kind": "title",
      "text": "Multi-asset, Late-stage Pipeline & Near-term Catalysts Expected",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b177e7d-bc1d-4f70-b016-a204d267b88a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 3,
      "beatId": "dd061c55-104a-4b61-98e2-4402947bffe6",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Situation & Context",
      "beatSlug": "consultants-gambit-situation-context",
      "evidence": "Slides 3-6 provide an overview of Oculis's purpose and pipeline.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "e5858f71-7892-4640-bcd5-6dc5fae5ed8f",
      "evidence": "Slides 3-6 provide an overview of Oculis's purpose and pipeline, framing the context for their solutions.",
      "position": 1,
      "objective": "Explain why Oculis's innovations matter",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}